Annovis (ANVS): Late-Stage Parkinson's Disease Trial Advancement Makes It Worth A Look

Annovis is targeting large market indications and the two of them are Alzheimer's and Parkinson's. See why I believe that ANVS is a great speculative biotech play.

Related Keywords

Annovis Bio ,Movement Disorder Society ,National Institutes Of Health ,Movement Disorder Society Sponsored Revision ,Unified Parkinson ,Disease Rating Scale ,Participant Global Impression ,Final Conclusion ,National Institutes ,